PLAINSBORO, N.J. (Feb. 2, 2015) – OncLive®
today welcomes the University of Chicago Medicine Comprehensive Cancer Center
as a partner in raising the standard of cancer care through OncLive’s Strategic Alliance Partnership program.
The new partnership enables OncLive’s editorial and marketing teams to increase awareness of the Center where more than 200 cancer specialists use innovative treatments, leading-edge research and clinical trials not available elsewhere to attack cancer from every angle. The Center has been designated by the National Cancer Institute as a Comprehensive Cancer Center, in recognition of its work in developing and translating scientific knowledge from promising laboratory discoveries into new treatments for cancer patients.
Mike J. Hennessy Jr., senior vice president, oncology & specialty pharmacy, which includes OncLive, said, “It is our honor to partner with the prestigious University of Chicago Medicine Comprehensive Cancer Center, which has been a leader in cancer research for more than 50 years. Its scientists and clinicians have consistently expanded the boundaries of knowledge and transformed cancer care and prevention. In fact, seminal discoveries made at UChicago have stimulated the development and introduction of many of the cancer treatments used today.”
Hennessy added, “The University of Chicago Medicine Comprehensive Cancer Center joins more than 30 other leading cancer centers, nursing schools and physician groups around the country in partnering with OncLive. These partnerships benefit all levels of healthcare professionals dedicated to combating cancer, as well as the patients they serve. By collaborating, sharing information and working together, we broaden opportunities to find the best approaches to fighting cancer.”About OncLive
OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News
, Oncology Nursing News
and Contemporary Oncology
. OncLive offers oncology professionals resources and information to provide the best care for their patients. Intellisphere, LLC, a leading provider of healthcare publishing, research and education, is part of the Michael J. Hennessy Associates, Inc.
(MJH) family of businesses, based in Plainsboro, N.J. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable. Its flagship product is CURE
magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers and advocacy groups. To learn more, please visit www.OncLive.com
.About the University of Chicago Medicine Comprehensive Cancer Center
The University of Chicago Medicine Comprehensive Cancer Center has been at the forefront of cancer care and discovery for more than 50 years. Many of the roots of chemotherapy, hormonal therapy, gene therapy and bone marrow transplantation can be traced back to the Cancer Center. More than 210 physician scientists are conducting basic, clinical and translational research to study cancer from all angles, enabling the incorporation of personalized medicine into routine care. The Cancer Center is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers,
a distinction that denotes scientific excellence, as well as discovery and development of effective approaches to cancer risk assessment, prevention, diagnosis, treatment, and survivorship. The Cancer Center has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer since 1999. For more information, visit cancer.uchicago.edu, Facebook, Twitter.
For UCCCC: Michelle Foley, 773.702.0025, Michelle.Foley@uchospitals.edu
For OncLive: Becky Taylor, 609.240.6886, email@example.com